Skip to content
2000
Volume 21, Issue 3
  • ISSN: 1573-3963
  • E-ISSN: 1875-6336

Abstract

Familial Hypercholesterolemia (FH) is one of the best-characterized inborn errors of metabolism, with an estimated prevalence of 1:250 in the general population. Only approximately 10% of the affected subjects are diagnosed and, therefore, under medical care, including drug therapy or, in severe cases, apheresis. Screening at the age of 6-10 years would be useful and cost-effective. There is enough evidence that children and adolescents with FH should be treated in order to reduce elevated Total cholesterol and LDL-c levels and, therefore, avoid the risk of early cardiovascular diseases.

As FH was described more than 130 years ago, it is surprising that the knowledge of that very important metabolic disorder is insufficient. The present report describes clinical and pathophysiological characteristics and nutritional and medical therapies in children with familial hypercholesterolemia.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cpr/10.2174/0115733963283106240712073530
2024-07-30
2025-09-06

  • From This Site

    /content/journals/cpr/10.2174/0115733963283106240712073530
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. WidhalmK. BenkeI.M. FritzM. GeigerH. HelkO. FritschM. HoermannG. KostnerG. Homozygous familial hypercholesterolemia: Summarized case reports.Atherosclerosis2017257868910.1016/j.atherosclerosis.2017.01.00228126585
     [Google Scholar]
  2. WidhalmK. Familial Hypercholesterolemia: An Insidious and dangerous Disease.Austrian Academic Institute for Clinical Nutrition2023
     [Google Scholar]
  3. WiegmanA. GiddingS.S. WattsG.F. ChapmanM.J. GinsbergH.N. CuchelM. OseL. AvernaM. BoileauC. BorénJ. BruckertE. CatapanoA.L. DefescheJ.C. DescampsO.S. HegeleR.A. HovinghG.K. HumphriesS.E. KovanenP.T. KuivenhovenJ.A. MasanaL. NordestgaardB.G. PajukantaP. ParhoferK.G. RaalF.J. RayK.K. SantosR.D. StalenhoefA.F.H. Steinhagen- ThiessenE. StroesE.S. TaskinenM.R. Tybjærg-HansenA. WiklundO. European Atherosclerosis Society Consensus Panel Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment.Eur. Heart J.201536362425243710.1093/eurheartj/ehv15726009596
     [Google Scholar]
  4. MigliaraG. BaccoliniV. RossoA. D’AndreaE. MassimiA. VillariP. De VitoC. Familial hypercholesterolemia: A systematic review of guidelines on genetic testing and patient management.Front. Public Health2017525210.3389/fpubh.2017.0025228993804
     [Google Scholar]
  5. StefanuttiC. JuliusU. WattsG.F. Harada-ShibaM. CossuM. SchettlerV.J. De SilvestroG. SoranH. Van LennepJ.R. PisciottaL. KlörH.U. WidhalmK. MoriartyP.M. D’AlessandriG. BianciardiG. BoscoG. De FuscoG. Di GiacomoS. MorozziC. MesceD. VitaleM. SovranoB. DrogariE. EwaldN. GualdiG. JaegerB.R. LantiA. MarsonP. MartinoF. MiglioriG. ParasassiT. PavanA. PerlaF.M. BrunelliR. PerroneG. RengaS. RiesW. RomanoN. RomeoS. PergoliniM. LabbadiaG. Di IorioB. De PaloT. AbbateR. MarcucciR. PoliL. ArdissinoG. OttoneP. TisonT. FavariE. BorgeseL. ShafiiM. GozzerM. PacellaE. TorromeoC. ParassassiT. BerniA. GuardamagnaO. ZentiM.G. GuitarriniM.R. BerrettiD. HohensteinB. SahebS. BjelakovicB. WilliamsH. De Luca N Toward an international consensus—Integrating lipoprotein apheresis and new lipid-lowering drugs.J. Clin. Lipidol.2017114858871.e310.1016/j.jacl.2017.04.11428572002
     [Google Scholar]
  6. CuchelM. BruckertE. GinsbergH.N. RaalF.J. SantosR.D. HegeleR.A. KuivenhovenJ.A. NordestgaardB.G. DescampsO.S. Steinhagen-ThiessenE. Tybjaerg-HansenA. WattsG.F. AvernaM. BoileauC. BorénJ. CatapanoA.L. DefescheJ.C. HovinghG.K. HumphriesS.E. KovanenP.T. MasanaL. PajukantaP. ParhoferK.G. RayK.K. StalenhoefA.F.H. StroesE. TaskinenM.R. WiegmanA. WiklundO. ChapmanM.J. CuchelM. BruckertE. ChapmanM.J. DescampsO.S. GinsbergH.N. HegeleR.A. KuivenhovenJ.A. NordestgaardB.G. RaalF.J. SantosR.D. Steinhagen-ThiessenE. Tybjaerg-HansenA. WattsG.F. ChapmanM.J. GinsbergH.N. AvernaM. BoileauC. BorenJ. CatapanoA.L. DefescheJ.C. HovinghG.K. HumphriesS.E. KovanenP.T. MasanaL. PajukantaP. ParhoferK.G. RayK.K. StalenhoefA.F.H. StroesE. TaskinenM-R. WiegmanA. WiklundO. European Atherosclerosis Society Consensus Panel on Familial Hypercholesterolaemia Homozygous familial hypercholesterolaemia: New insights and guidance for clinicians to improve detection and clinical management. A position paper from the consensus panel on familial hypercholesterolaemia of the european atherosclerosis society.Eur. Heart J.201435322146215710.1093/eurheartj/ehu27425053660
     [Google Scholar]
  7. Widhalm KK. Sudden death in a 4-year old boy: A near-complete occlusion of the coronary artery caused by an aggressive low-density lipoprotein receptor mutation (W5566) in homozygous familial hypercholesterolemia.J. Pediatr.201115816710.1016/j.jpeds.2010.06.02720659736
     [Google Scholar]
  8. KheraA.V. WonH-H. Diagnostic yield of sequencing familial hypercholesterolemia genes in severe hypercholesterolemia.J. Am. Coll. Cardiol.201667222578258910.1016/j.jacc.2016.03.52027050191
     [Google Scholar]
  9. ThompsonG.R. BlomD.J. MaraisA.D. SeedM. PilcherG.J. RaalF.J. Survival in homozygous familial hypercholesterolaemia is determined by the on-treatment level of serum cholesterol.Eur. Heart J.201839141162116810.1093/eurheartj/ehx31729106543
     [Google Scholar]
  10. PalmaL. WeldingM. O’SheaJ. Diagnosis and treatment of familial hypercholesterolemia.Nurse Pract.2016418364310.1097/01.NPR.0000488711.52197.bd27414814
     [Google Scholar]
  11. Harada-ShibaM. OhtaT. OhtakeA. OguraM. DobashiK. NoharaA. YamashitaS. YokoteK. Joint Working Group by Japan Pediatric Society and Japan Atherosclerosis Society for Making Guidance of Pediatric Familial Hypercholesterolemia Guidance for pediatric familial hypercholesterolemia 2017.J. Atheroscler. Thromb.201825653955310.5551/jat.CR00229415907
     [Google Scholar]
  12. AmundsenÅ.L. OseL. NenseterM.S. NtaniosF.Y. Plant sterol ester–enriched spread lowers plasma total and LDL cholesterol in children with familial hypercholesterolemia.Am. J. Clin. Nutr.200276233834410.1093/ajcn/76.2.33812145004
     [Google Scholar]
  13. NordestgaardB.G. ChapmanM.J. HumphriesS.E. GinsbergH.N. MasanaL. DescampsO.S. WiklundO. HegeleR.A. RaalF.J. DefescheJ.C. WiegmanA. SantosR.D. WattsG.F. ParhoferK.G. HovinghG.K. KovanenP.T. BoieauC. AvernaM. BorénJ. BruckertE. CatapanoA.L. KuivenhovenJ.A. PajukantaP. RayK. StalenhoefA.F.H. StroesE. TaskinenM.R. Tybjaerg-HansenA. Familial hypercholesterolaemia is underdiagnoses and undertreated in the general population: Guidance for clinicians to prevent coronary heart disease.Eur. Heart J.2013343478349010.1093/eurheartj/eht27323956253
     [Google Scholar]
  14. GyllingH. SiimesM.A. MiettinenT.A. Sitostanol ester margarine in dietary treatment of children with familial hypercholesterolemia.J. Lipid Res.19953681807181210.1016/S0022‑2275(20)41499‑37595101
     [Google Scholar]
  15. GoldbergA.C. HopkinsP.N. TothP.P. BallantyneC.M. RaderD.J. RobinsonJ.G. DanielsS.R. GiddingS.S. de FerrantiS.D. ItoM.K. McGowanM.P. MoriartyP.M. CromwellW.C. RossJ.L. ZiajkaP.E. Familial hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients.J. Clin. Lipidol.20115313314010.1016/j.jacl.2011.03.00121600517
     [Google Scholar]
  16. OseL. Diagnostic, clinical, and therapeutic aspects of familial hypercholesterolemia in children.Semin. Vasc. Med.200441515710.1055/s‑2004‑82298615199433
     [Google Scholar]
  17. WidhalmK. StefanuttiC. History of familial hypercholesterolemia.J Case Rep Med Hist 2023341510.54289/JCRMH2300119
     [Google Scholar]
  18. KustersD.M. de BeaufortC. WidhalmK. GuardamagnaO. BratinaN. OseL. WiegmanA. Paediatric screening for hypercholesterolaemia in Europe: Table 1.Arch. Dis. Child.201297327227610.1136/archdischild‑2011‑30008121949015
     [Google Scholar]
  19. KnowlesJ.W. RaderD.J. KhouryM.J. Cascade screening for familial hypercholesterolemia and the use of genetic testing.JAMA2017318438138210.1001/jama.2017.854328742895
     [Google Scholar]
  20. AlonsoR. MataP. ZambónD. MataN. Fuentes-JiménezF. Early diagnosis and treatment of familial hypercholesterolemia: Improving patient outcomes.Expert Rev. Cardiovasc. Ther.201311332734210.1586/erc.13.723469913
     [Google Scholar]
  21. RamaswamiU. HumphriesS.E. Management of familial hypercholesterolaemia in childhood.Curr. Opin. Pediatr.202032563364010.1097/MOP.000000000000094332833799
     [Google Scholar]
  22. WidhalmK. BrazdaG. SchneiderB. KohlS. Effect of soy protein diet versus standard low fat, low cholesterol diet on lipid and lipoprotein levels in children with familial or polygenic hypercholesterolemia.J. Pediatr.19931231303410.1016/S0022‑3476(05)81533‑18320622
     [Google Scholar]
  23. De JonghS. VissersM.N. RolP. BakkerH.D. KasteleinJ.J.P. StroesE.S.G. Plant sterols lower LDL cholesterol without improving endothelial function in prepubertal children with familial hypercholesterolaemia.J. Inherit. Metab. Dis.200326434335210.1023/A:102515500234812971422
     [Google Scholar]
  24. WeghuberD. WidhalmK. Effect of 3-month treatment of children and adolescents with familial and polygenic hypercholesterolaemia with a soya-substituted diet.Br. J. Nutr.200899228128610.1017/S000711450780799917697400
     [Google Scholar]
  25. HelkO. WidhalmK. Effects of a low-fat dietary regimen enriched with soy in children affected with heterozygous familial hypercholesterolemia.Clin. Nutr. ESPEN20203615015610.1016/j.clnesp.2019.09.00932220359
     [Google Scholar]
  26. NegeleL. SchneiderB. RistlR. StulnigT.M. Willfort-EhringerA. HelkO. WidhalmK. Effect of a low-fat diet enriched either with rapeseed oil or sunflower oil on plasma lipoproteins in children and adolescents with familial hypercholesterolaemia. Results of a pilot study.Eur. J. Clin. Nutr.201569333734310.1038/ejcn.2014.23425424602
     [Google Scholar]
  27. LaurinD. JacquesH. MoorjaniS. SteinkeF.H. GagnéC. BrunD. LupienP.J. Effects of a soy-protein beverage on plasma lipoproteins in children with familial hypercholesterolemia.Am. J. Clin. Nutr.19915419810310.1093/ajcn/54.1.982058593
     [Google Scholar]
  28. TonstadS. SivertsenM. Dietary adherence in children with familial hypercholesterolemia.Am. J. Clin. Nutr.19976541018102610.1093/ajcn/65.4.10189094888
     [Google Scholar]
  29. JakuljL. VissersM.N. RodenburgJ. WiegmanA. TripM.D. KasteleinJ.J.P. Plant stanols do not restore endothelial function in pre-pubertal children with familial hypercholesterolemia despite reduction of low-density lipoprotein cholesterol levels.J. Pediatr.2006148449550010.1016/j.jpeds.2005.11.02316647412
     [Google Scholar]
  30. GulesserianT. WidhalmK. Effect of a rapeseed oil substituting diet on serum lipids and lipoproteins in children and adolescents with familial hypercholesterolemia.J. Am. Coll. Nutr.200221210310810.1080/07315724.2002.1071920111999536
     [Google Scholar]
  31. MasanaL. CiveiraF. Pedro-BotetJ. de CastroI. PocovíM. PlanaN. Mateo-GallegoR. JarautaE. PedragosaÀ. Expert consensus on the detection and clinical management of familial hypercholesterolemia.Clin. Investig. Arterioscler.201325418219324041477
     [Google Scholar]
  32. HumphriesS.E. Guidelines for the identification and management of patients with familial hypercholesterolaemia (FH): Are we coming to a consensus?Atheroscler. Suppl.201112221722010.1016/S1567‑5688(11)00037‑722230092
     [Google Scholar]
  33. FeldmanD.I. BlahaM.J. SantosR.D. JonesS.R. BlumenthalR.S. TothP.P. SperlingL.S. MartinS.S. Recommendations for the management of patients with familial hypercholesterolemia.Curr. Atheroscler. Rep.201517147310.1007/s11883‑014‑0473‑625404096
     [Google Scholar]
  34. DanielsS.R. Pediatric guidelines for dyslipidemia.J. Clin. Lipidol.201595Suppl.S5S1010.1016/j.jacl.2015.03.10526343212
     [Google Scholar]
  35. WidhalmK. DirisamerA. LindemayrA. KostnerG. Diagnosis of families with familial hypercholesterolaemia and/or Apo B-100 defect by means of DNA analysis of LDL-receptor gene mutations.J. Inherit. Metab. Dis.200730223924710.1007/s10545‑007‑0563‑517347910
     [Google Scholar]
  36. StefanuttiC. JuliusU. WattsG.F. Changing characteristics of obese children and adolescents entering pediatric lifestyle intervention programs in germany over the last 11 years: An adiposity patients registry multicenter analysis of 65,453 children and adolescents..Obes. Facts201710551753029131049
     [Google Scholar]
  37. MyśliwiecM. WalczakM. Małecka-TenderaE. DobrzańskaA. CybulskaB. FilipiakK. MazurA. Jarosz-ChobotP. SzadkowskaA. RynkiewiczA. ChybickaA. SochaP. BrandtA. Bautembach-MinkowskaJ. ZdrojewskiT. LimonJ. GiddingS.S. BanachM. Management of familial hypercholesterolemia in children and adolescents. Position paper of the Polish Lipid Expert Forum.J. Clin. Lipidol.20148217318010.1016/j.jacl.2014.01.00124636176
     [Google Scholar]
/content/journals/cpr/10.2174/0115733963283106240712073530
Loading
Clinical Management of Familial Hypercholesterolemia in Children
Curr Pediatr Rev 21, 213 (2025); https://doi.org/10.2174/0115733963283106240712073530
/content/journals/cpr/10.2174/0115733963283106240712073530
/content/journals/cpr/10.2174/0115733963283106240712073530
Loading

Data & Media loading...


  • Article Type:     Rapid Communication
Keyword(s): adolescents; cardiovascular diseases; children; diet; drugs; Familial hypercholesterolemia; nutrition

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test